Accumulation of debrisoquin-14C by the human platelet.
D000578:Amidines / Q000378:metabolism*; D000959:Antihypertensive Agents / Q000378:metabolism; D001665:Binding Sites / Q000187:drug effects; D001693:Biological Transport, Active / Q000187:drug effects; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D001949:Bretylium Compounds / Q000494:pharmacology; D002247:Carbon Isotopes; D003486:Cyanides / Q000494:pharmacology; D005459:Fluorides / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006801:Humans; D007461:Iodoacetates / Q000494:pharmacology; D007546:Isoquinolines / Q000378:metabolism*; D007700:Kinetics; D009474:Neurons / Q000187:drug effects; D010042:Ouabain / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology
D000578:Amidines; D000959:Antihypertensive Agents; D001949:Bretylium Compounds; D002247:Carbon Isotopes; D003486:Cyanides; D007461:Iodoacetates; D007546:Isoquinolines; D012701:Serotonin; D010042:Ouabain; D012110:Reserpine; D005459:Fluorides; D014439:Tyramine; D006145:Guanethidine